Joshua H. Bilenker
CIK 1612312 · President & CEO · last filed 2026-06-05
Joshua H. Bilenker is a President & CEO who has filed 41 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for SANA, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$42.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $53.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$53.6K
5
41
-$42.73M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | 20,000 | $2.68 | $53.6K | $500.0K | 9 | 2026-06-05 |
| GOSS | Director | — | $0.16 | — | $0 | 4 | 2022-07-15 |
| Loxo Oncology, Inc. (LOXO) Delisted | President & CEO | 0 | — | — | -$43.23M | 25 | 2019-02-15 |
| ViewRay, Inc. (VRAY) Delisted | Director | 7,480,887 | $0.03 | $187.0K | $0 | 1 | 2016-09-15 |
| TTOO | Director | — | $0.00 | — | $0 | 2 | 2016-06-21 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-07-15 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | SANA | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2023-02-17 | SANA | Buy (P) | +20,000 | $500.0K | EDGAR |
| 2022-07-15 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | SANA | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | SANA | Grant (A) | — | $0 | EDGAR |